765
Participants
Start Date
December 31, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2027
electronic clinical decision support tool (eCDST) diagnostic plan
Participants will be followed for 30 days from enrollment to record clinical outcomes and any antimicrobials used. Analyses will compare clinical outcomes and antimicrobial use between the intervention arm and usual care.
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Duke University
OTHER